Fibromyalgia - Xconomy

by in

Entry	Author	Date	Location
Cypress Bio Rejects Buyout Again, Calls Offer Opportunistic, Undervalued	Bruce V. Bigelow	09/28/10	San Diego
In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer	Bruce V. Bigelow	09/15/10	San Diego
Cypress Bio Rejects Buyout Offer, Shutting Down Commercial Business	Bruce V. Bigelow	08/06/10	San Diego
Cypress Shipping Fibromyalgia Drug	Bruce V. Bigelow	05/11/09	San Diego
Fibromyalgia Drug Delayed	Bruce V. Bigelow	03/08/09	San Diego
Cypress Buys Lupus Test	Luke Timmerman	02/24/09	San Diego
San Diego Biotechs With Good News Step Forward at Roth Conference	Bruce V. Bigelow	02/18/09	San Diego
Cypress Bioscience Shares Soar on News of FDA Approval	Bruce V. Bigelow	01/15/09	San Diego
Cypress Bioscience Drug Succeeds in Fibromyalgia Study	Luke Timmerman	12/08/08	San Diego
Cypress Fibromyalgia Drug Stalled by FDA	Luke Timmerman	10/20/08	San Diego
Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadline	Luke Timmerman	10/10/08	San Diego
Page 1 of 1

Xconomy National